Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Driven by the downstream end-users, the market of Radioactive Monoclonal Antibody witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Radioactive Monoclonal Antibody market is offered. The research provides insights for the global Radioactive Monoclonal Antibody market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Radioactive Monoclonal Antibody industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Radioactive Monoclonal Antibody Market Segmentations:
By Players:
F. Hoffmann-La Roche Ltd. (Switzerland)
Progenics Pharmaceuticals, Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)
Abbott Laboratories (USA)
Genentech Inc. (USA)
Spectrum Pharmaceuticals, Inc. (USA)
Bristol-Myers Squibb Company (USA)
Sanofi-Aventis SA (France)
Amgen Inc. (USA)
EUSA Pharma, (USA) Inc. (USA)
Medimmune, LLC (USA)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Pfizer Inc. (USA)
Paladin Labs Inc. (Canada)
Cell Genesys Inc. (USA)
AstraZeneca PLC (UK)
Dendreon Corporation (USA)
GlaxoSmithKline Plc (UK)
ALZA Corporation (USA)
By Types:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Reasons to Purchase the Radioactive Monoclonal Antibody Market Report
-
Vertical Market Divisions by Type and End-Users
-
The Most Promising Regions in the Forecast Period
-
Competitive Landscape
-
Key Players’ Strategies and Their Product Offerings
-
Radioactive Monoclonal Antibody Market Current Trends/Restraints/Challenges/Opportunities
-
Potential and Niche Market / Regions with Promising Growth
-
Objective Analysis Towards Market Performance
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Radioactive Monoclonal Antibody Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Radioactive Monoclonal Antibody Market Share by Types
1.3.2 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 1 from 2013 to 2025
1.3.3 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 2 from 2013 to 2025
1.3.4 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 3 from 2013 to 2025
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Radioactive Monoclonal Antibody Market Share by End-Users
1.4.2 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 1 from 2013 to 2025
1.4.3 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 2 from 2013 to 2025
1.4.4 Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 3 from 2013 to 2025
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.1 United States Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.2 Canada Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.3 Mexico Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2 Europe Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.1 Germany Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.2 UK Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.3 France Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.4 Italy Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.5 Nordic Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.6 Spain Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.7 BelgiumRadioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.8 Poland Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.9 Russia Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.10 Turkey Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3 Asia-Pacific Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.1 China Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.2 Japan Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.3 Australia and New Zealand Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.4 India Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.5 ASEAN Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.6 South Korea Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.1 GCC Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.2 Brazil Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.3 Nigeria Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.4 South Africa Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.5 Argentina Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Radioactive Monoclonal Antibody Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Radioactive Monoclonal Antibody by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Radioactive Monoclonal Antibody Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Radioactive Monoclonal Antibody by Major End-Users
4.4.1 Market Size and Growth Rate of Radioactive Monoclonal Antibody for End-Users 1
4.4.2 Market Size and Growth Rate of Radioactive Monoclonal Antibody for End-Users 2
4.4.3 Market Size and Growth Rate of Radioactive Monoclonal Antibody for End-Users 3
5 Market Analysis by Major Regions
-
5.1 Global Radioactive Monoclonal Antibody Production Analysis by Major Regions
-
5.2 Global Radioactive Monoclonal Antibody Consumption Analysis by Major Regions
-
5.3 Global Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
6 Product Commodity of Radioactive Monoclonal Antibody Market in Major Countries
-
6.1 Top 5 Export Countries in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.2 Top 5 Import Countries in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Radioactive Monoclonal Antibody Landscape Analysis
-
7.1 North America Radioactive Monoclonal Antibody Landscape Analysis by Major Types
-
7.2 North America Radioactive Monoclonal Antibody Landscape Analysis by Major End-Users
-
7.3 North America Radioactive Monoclonal Antibody Landscape Analysis by Major Countries
-
7.3.1 United States Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
7.3.2 Canada Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
7.3.3 Mexico Radioactive Monoclonal Antibody Market Volume and Growth Rate
8 Europe Radioactive Monoclonal Antibody Landscape Analysis
-
8.1 Europe Radioactive Monoclonal Antibody Landscape Analysis by Major Types
-
8.2 Europe Radioactive Monoclonal Antibody Landscape Analysis by Major End-Users
-
8.3 Europe Radioactive Monoclonal Antibody Landscape Analysis by Major Countries
-
8.3.1 Germany Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.2 UK Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.3 France Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.4 Italy Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.5 Nordic Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.6 Spain Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.7 Belgium Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.8 Poland Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.9 Russia Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
8.3.10 Turkey Radioactive Monoclonal Antibody Market Volume and Growth Rate
9 Asia Pacific Radioactive Monoclonal Antibody Landscape Analysis
-
9.1 Asia Pacific Radioactive Monoclonal Antibody Landscape Analysis by Major Types
-
9.2 Asia Pacific Radioactive Monoclonal Antibody Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Radioactive Monoclonal Antibody Landscape Analysis by Major Countries
-
9.3.1 China Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
9.3.2 Japan Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
9.3.4 India Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
9.3.6 South Korea Radioactive Monoclonal Antibody Market Volume and Growth Rate
10 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Landscape Analysis
-
10.1 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Radioactive Monoclonal Antibody Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
10.3.2 Brazil Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
10.3.3 Nigeria Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
10.3.4 South Africa Radioactive Monoclonal Antibody Market Volume and Growth Rate
-
10.3.5 Argentina Radioactive Monoclonal Antibody Market Volume and Growth Rate
11 Major Players Profile
11.1 F. Hoffmann-La Roche Ltd. (Switzerland)
11.1.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile and Development Status
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Progenics Pharmaceuticals, Inc. (USA)
11.2.1 Progenics Pharmaceuticals, Inc. (USA) Company Profile and Development Status
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 Takeda Pharmaceutical Company Limited (Japan)
11.3.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile and Development Status
11.3.2 Market Performance
11.3.3 Product and Service Introduction
11.4 Abbott Laboratories (USA)
11.4.1 Abbott Laboratories (USA) Company Profile and Development Status
11.4.2 Market Performance
11.4.3 Product and Service Introduction
11.5 Genentech Inc. (USA)
11.5.1 Genentech Inc. (USA) Company Profile and Development Status
11.5.2 Market Performance
11.5.3 Product and Service Introduction
11.6 Spectrum Pharmaceuticals, Inc. (USA)
11.6.1 Spectrum Pharmaceuticals, Inc. (USA) Company Profile and Development Status
11.6.2 Market Performance
11.6.3 Product and Service Introduction
11.7 Bristol-Myers Squibb Company (USA)
11.7.1 Bristol-Myers Squibb Company (USA) Company Profile and Development Status
11.7.2 Market Performance
11.7.3 Product and Service Introduction
11.8 Sanofi-Aventis SA (France)
11.8.1 Sanofi-Aventis SA (France) Company Profile and Development Status
11.8.2 Market Performance
11.8.3 Product and Service Introduction
11.9 Amgen Inc. (USA)
11.9.1 Amgen Inc. (USA) Company Profile and Development Status
11.9.2 Market Performance
11.9.3 Product and Service Introduction
11.10 EUSA Pharma, (USA) Inc. (USA)
11.10.1 EUSA Pharma, (USA) Inc. (USA) Company Profile and Development Status
11.10.2 Market Performance
11.10.3 Product and Service Introduction
11.11 Medimmune, LLC (USA)
11.11.1 Medimmune, LLC (USA) Company Profile and Development Status
11.11.2 Market Performance
11.11.3 Product and Service Introduction
11.12 Immunomedics, Inc. (USA)
11.12.1 Immunomedics, Inc. (USA) Company Profile and Development Status
11.12.2 Market Performance
11.12.3 Product and Service Introduction
11.13 Indevus Pharmaceuticals Inc. (USA)
11.13.1 Indevus Pharmaceuticals Inc. (USA) Company Profile and Development Status
11.13.2 Market Performance
11.13.3 Product and Service Introduction
11.14 Novartis AG (Switzerland)
11.14.1 Novartis AG (Switzerland) Company Profile and Development Status
11.14.2 Market Performance
11.14.3 Product and Service Introduction
11.15 OSI Pharmaceuticals, Inc. (USA)
11.15.1 OSI Pharmaceuticals, Inc. (USA) Company Profile and Development Status
11.15.2 Market Performance
11.15.3 Product and Service Introduction
11.16 Pfizer Inc. (USA)
11.16.1 Pfizer Inc. (USA) Company Profile and Development Status
11.16.2 Market Performance
11.16.3 Product and Service Introduction
11.17 Paladin Labs Inc. (Canada)
11.17.1 Paladin Labs Inc. (Canada) Company Profile and Development Status
11.17.2 Market Performance
11.17.3 Product and Service Introduction
11.18 Cell Genesys Inc. (USA)
11.18.1 Cell Genesys Inc. (USA) Company Profile and Development Status
11.18.2 Market Performance
11.18.3 Product and Service Introduction
11.19 AstraZeneca PLC (UK)
11.19.1 AstraZeneca PLC (UK) Company Profile and Development Status
11.19.2 Market Performance
11.19.3 Product and Service Introduction
11.20 Dendreon Corporation (USA)
11.20.1 Dendreon Corporation (USA) Company Profile and Development Status
11.20.2 Market Performance
11.20.3 Product and Service Introduction
11.21 GlaxoSmithKline Plc (UK)
11.21.1 GlaxoSmithKline Plc (UK) Company Profile and Development Status
11.21.2 Market Performance
11.21.3 Product and Service Introduction
11.22 ALZA Corporation (USA)
11.22.1 ALZA Corporation (USA) Company Profile and Development Status
11.22.2 Market Performance
11.22.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 102 Figures and 157 Tables)
-
Figure Product Picture
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 1 from 2013 to 2025
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 2 from 2013 to 2025
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of Type 3 from 2013 to 2025
-
Figure Market Share by Type in 2013
-
Figure Market Share by Type in 2017
-
Figure Market Share by Type in 2025
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 1 from 2013 to 2025
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 2 from 2013 to 2025
Figure Global Radioactive Monoclonal Antibody Market Size and Growth Rate of End-User 3 from 2013 to 2025
-
Figure Market Share by End-User in 2013
-
Figure Market Share by End-User in 2017
-
Figure Market Share by End-User in 2025
-
Figure North America Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure United States Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Canada Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Mexico Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Europe Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Germany Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure UK Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure France Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Italy Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Nordic Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Spain Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Belgium Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Poland Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Russia Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Turkey Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Asia-Pacific Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure China Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Japan Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Australia and New Zealand Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure India Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure ASEAN Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure South Korea Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure GCC Countries Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Brazil Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Nigeria Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure South Africa Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Argentina Radioactive Monoclonal Antibody Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Development Trends and Industry Dynamics of Radioactive Monoclonal Antibody Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2017
-
Figure Market Share of TOP 5 Players in 2017
-
Figure Market Share of TOP 6 Players from 2013 to 2018
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Radioactive Monoclonal Antibody
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Radioactive Monoclonal Antibody by Different Types from 2013 to 2025
-
Table Consumption Share of Radioactive Monoclonal Antibody by Different Types from 2013 to 2025
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Radioactive Monoclonal Antibody by Different End-Users from 2013 to 2025
-
Table Consumption Share of Radioactive Monoclonal Antibody by Different End-Users from 2013 to 2025
Figure Market Size and Growth Rate of End-User 1
Figure Market Size and Growth Rate of End-User 2
Figure Market Size and Growth Rate of End-User 3
-
Table Global Radioactive Monoclonal Antibody Production by Major Regions
-
Table Global Radioactive Monoclonal Antibody Production Share by Major Regions
-
Figure Global Radioactive Monoclonal Antibody Production Share by Major Regions in 2013
-
Figure Global Radioactive Monoclonal Antibody Production Share by Major Regions in 2018
-
Figure Global Radioactive Monoclonal Antibody Production Share by Major Regions in 2025
-
Table Global Radioactive Monoclonal Antibody Consumption by Major Regions
-
Table Global Radioactive Monoclonal Antibody Consumption Share by Major Regions
-
Figure Global Radioactive Monoclonal Antibody Consumption Share by Major Regions in 2013
-
Figure Global Radioactive Monoclonal Antibody Consumption Share by Major Regions in 2018
-
Figure Global Radioactive Monoclonal Antibody Consumption Share by Major Regions in 2025
-
Table North America Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
Table Europe Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
Table Top 5 Export Countries' Export Volume Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
Table Top 5 Import Countries' Import Value Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
Table Top 5 Import Countries' Import Volume Analysis in Radioactive Monoclonal Antibody market from 2013 to 2018
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Radioactive Monoclonal Antibody Consumption by Types from 2013 to 2025
-
Table North America Radioactive Monoclonal Antibody Consumption Share by Types from 2013 to 2025
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Types in 2013
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Types in 2018
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Types in 2025
-
Table North America Radioactive Monoclonal Antibody Consumption by End-Users from 2013 to 2025
-
Table North America Radioactive Monoclonal Antibody Consumption Share by End-Users from 2013 to 2025
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by End-Users in 2013
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by End-Users in 2018
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by End-Users in 2025
-
Table North America Radioactive Monoclonal Antibody Consumption by Major Countries from 2013 to 2025
-
Table North America Radioactive Monoclonal Antibody Consumption Share by Major Countries from 2013 to 2025
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2013
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2018
-
Figure North America Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2025
-
Figure United States Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Canada Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Mexico Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption by Types from 2013 to 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption Share by Types from 2013 to 2025
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Types in 2013
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Types in 2018
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Types in 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption by End-Users from 2013 to 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption Share by End-Users from 2013 to 2025
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by End-Users in 2013
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by End-Users in 2018
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by End-Users in 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption by Major Countries from 2013 to 2025
-
Table Europe Radioactive Monoclonal Antibody Consumption Share by Major Countries from 2013 to 2025
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2013
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2018
-
Figure Europe Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2025
-
Figure Germany Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure UK Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure France Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Italy Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Nordic Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Belgium Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Poland Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Russia Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Turkey Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption by Types from 2013 to 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Types from 2013 to 2025
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Types in 2013
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Types in 2018
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Types in 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption by End-Users from 2013 to 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption Share by End-Users from 2013 to 2025
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by End-Users in 2013
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by End-Users in 2018
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by End-Users in 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption by Major Countries from 2013 to 2025
-
Table Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Major Countries from 2013 to 2025
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2013
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2025
-
Figure China Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Japan Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Australia and New ZealandRadioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure India Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure ASEAN Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure South Korea Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption by Types from 2013 to 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Types from 2013 to 2025
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Types in 2013
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Types in 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption by End-Users from 2013 to 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by End-Users from 2013 to 2025
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by End-Users in 2013
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by End-Users in 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption by Major Countries from 2013 to 2025
-
Table Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Major Countries from 2013 to 2025
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2013
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Radioactive Monoclonal Antibody Consumption Share by Major Countries in 2025
-
Figure GCC Countries Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Brazil Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Nigeria Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure South Africa Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
-
Figure Argentina Radioactive Monoclonal Antibody Market Volume and Growth Rate from 2013 to 2025
Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Product and Service Introduction of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of Progenics Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited (Japan)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited (Japan)
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited (Japan)
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited (Japan)
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited (Japan)
Table Company Profile and Development Status of Abbott Laboratories (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories (USA)
Figure Sales and Growth Rate Analysis of Abbott Laboratories (USA)
Figure Revenue and Market Share Analysis of Abbott Laboratories (USA)
Table Product and Service Introduction of Abbott Laboratories (USA)
Table Company Profile and Development Status of Genentech Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc. (USA)
Figure Sales and Growth Rate Analysis of Genentech Inc. (USA)
Figure Revenue and Market Share Analysis of Genentech Inc. (USA)
Table Product and Service Introduction of Genentech Inc. (USA)
Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Bristol-Myers Squibb Company (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company (USA)
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company (USA)
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company (USA)
Table Product and Service Introduction of Bristol-Myers Squibb Company (USA)
Table Company Profile and Development Status of Sanofi-Aventis SA (France)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA (France)
Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA (France)
Figure Revenue and Market Share Analysis of Sanofi-Aventis SA (France)
Table Product and Service Introduction of Sanofi-Aventis SA (France)
Table Company Profile and Development Status of Amgen Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc. (USA)
Figure Sales and Growth Rate Analysis of Amgen Inc. (USA)
Figure Revenue and Market Share Analysis of Amgen Inc. (USA)
Table Product and Service Introduction of Amgen Inc. (USA)
Table Company Profile and Development Status of EUSA Pharma, (USA) Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Sales and Growth Rate Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Revenue and Market Share Analysis of EUSA Pharma, (USA) Inc. (USA)
Table Product and Service Introduction of EUSA Pharma, (USA) Inc. (USA)
Table Company Profile and Development Status of Medimmune, LLC (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune, LLC (USA)
Figure Sales and Growth Rate Analysis of Medimmune, LLC (USA)
Figure Revenue and Market Share Analysis of Medimmune, LLC (USA)
Table Product and Service Introduction of Medimmune, LLC (USA)
Table Company Profile and Development Status of Immunomedics, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (USA)
Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (USA)
Figure Revenue and Market Share Analysis of Immunomedics, Inc. (USA)
Table Product and Service Introduction of Immunomedics, Inc. (USA)
Table Company Profile and Development Status of Indevus Pharmaceuticals Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc. (USA)
Table Product and Service Introduction of Indevus Pharmaceuticals Inc. (USA)
Table Company Profile and Development Status of Novartis AG (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)
Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)
Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)
Table Product and Service Introduction of Novartis AG (Switzerland)
Table Company Profile and Development Status of OSI Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of OSI Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of OSI Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of Pfizer Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc. (USA)
Figure Sales and Growth Rate Analysis of Pfizer Inc. (USA)
Figure Revenue and Market Share Analysis of Pfizer Inc. (USA)
Table Product and Service Introduction of Pfizer Inc. (USA)
Table Company Profile and Development Status of Paladin Labs Inc. (Canada)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc. (Canada)
Figure Sales and Growth Rate Analysis of Paladin Labs Inc. (Canada)
Figure Revenue and Market Share Analysis of Paladin Labs Inc. (Canada)
Table Product and Service Introduction of Paladin Labs Inc. (Canada)
Table Company Profile and Development Status of Cell Genesys Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc. (USA)
Figure Sales and Growth Rate Analysis of Cell Genesys Inc. (USA)
Figure Revenue and Market Share Analysis of Cell Genesys Inc. (USA)
Table Product and Service Introduction of Cell Genesys Inc. (USA)
Table Company Profile and Development Status of AstraZeneca PLC (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC (UK)
Figure Sales and Growth Rate Analysis of AstraZeneca PLC (UK)
Figure Revenue and Market Share Analysis of AstraZeneca PLC (UK)
Table Product and Service Introduction of AstraZeneca PLC (UK)
Table Company Profile and Development Status of Dendreon Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation (USA)
Figure Sales and Growth Rate Analysis of Dendreon Corporation (USA)
Figure Revenue and Market Share Analysis of Dendreon Corporation (USA)
Table Product and Service Introduction of Dendreon Corporation (USA)
Table Company Profile and Development Status of GlaxoSmithKline Plc (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc (UK)
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc (UK)
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc (UK)
Table Product and Service Introduction of GlaxoSmithKline Plc (UK)
Table Company Profile and Development Status of ALZA Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation (USA)
Figure Sales and Growth Rate Analysis of ALZA Corporation (USA)
Figure Revenue and Market Share Analysis of ALZA Corporation (USA)
Table Product and Service Introduction of ALZA Corporation (USA)
-
